The largest database of trusted experimental protocols

3 protocols using nocodazole

1

Mitotic Arrest and Synchronization Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa S3 and HEK293 cells were cultured at 37 °C in 5% CO2 in Dulbecco’s Modified Eagle Medium (DMEM) (Cellgro, Herndon, VA) supplemented with 10% Fetal Bovine Serum (FBS) (Mediatech, Herndon, VA), and 1% Penicillin-Streptomycin (Mediatech). HeLa-Flag-YY1 cells are stably transfected with pCS2(+)-Flag-YY1, the generation of this cell line has been previously described28 . Cells were arrested at pro-metaphase of mitosis by adding nocodazole (100 ng/ml) or Taxol (100 nM) (Sigma) for 16–18 hours; cells were then collected by shake-off. For thymidine-nocodazole synchronisation, cells were blocked in thymidine (Sigma) at 2.5 mM for 18 hours, released for 3 hours, and then nocodazole was added for 12 hours. Cells were then collected, washed, and re-plated into fresh media to progress through mitosis. For the inhibition of Aurora A activity, VX-680 (LC Laboratories, Woburn, MZ) was added, for 15 minutes, to cells blocked in mitosis by nocodazole. For Aurora A knockdown, cells were transfected with control scrambled siRNA or Aurora A siRNA (50 nM) using DharmaFECT reagent (Dharmacon, Chicago, IL). After 36 hours of knockdown, the cells were blocked in mitosis with nocodazole for 18 hours. For transfection of mammalian expression plasmids, the Polyjet transfection reagent (SignaGen, Rockville, MD) was used according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Cell Line Characterization and Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, HeLa, SKOV3, TOV21G, OVCAR3, OVCAR8, and MCF7 cell lines were purchased from American Type Culture Collection (ATCC). The cell lines were authenticated at ATCC and were used at low (<30) passages. SKOV3 cells were maintained in McCoy’s 5A media, TOV21G cells were cultured in 1:1 mixture of MCDB 105 media and Medium 199, and MCF7 cells were maintained in MEM media with 0.01 mg/ml human recombinant insulin. Other cell lines were maintained in DMEM media and all cell lines were supplemented with 10% FBS and 1% penicillin/streptomycin. The isogenic cell lines (SKOV3 and SKOV3-TR) were obtained from Dr. Michael Seiden (32 (link)). Attractene (Qiagen) was used for transient overexpression following the manufacturer’s instructions. Nocodazole (100 ng/ml for 16–20 h) and Taxol (0.1 μM for 16 h) from LC laboratories were used to arrest cells in mitosis phase unless otherwise indicated. PKR inhibitor imidazole-oxindole C16 was from Sigma. Bcl2-specific inhibitor venetoclax/ABT199 were from AbbVie and Genentech (animal use) and LC Laboratory (for in vitro use). The use of other kinase inhibitors has been described (33 (link),34 (link)).
+ Open protocol
+ Expand
3

Cell Line Characterization and Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T, HeLa, SKOV3, TOV21G, OVCAR3, OVCAR8, and MCF7 cell lines were purchased from American Type Culture Collection (ATCC). The cell lines were authenticated at ATCC and were used at low (<30) passages. SKOV3 cells were maintained in McCoy’s 5A media, TOV21G cells were cultured in 1:1 mixture of MCDB 105 media and Medium 199, and MCF7 cells were maintained in MEM media with 0.01 mg/ml human recombinant insulin. Other cell lines were maintained in DMEM media and all cell lines were supplemented with 10% FBS and 1% penicillin/streptomycin. The isogenic cell lines (SKOV3 and SKOV3-TR) were obtained from Dr. Michael Seiden (32 (link)). Attractene (Qiagen) was used for transient overexpression following the manufacturer’s instructions. Nocodazole (100 ng/ml for 16–20 h) and Taxol (0.1 μM for 16 h) from LC laboratories were used to arrest cells in mitosis phase unless otherwise indicated. PKR inhibitor imidazole-oxindole C16 was from Sigma. Bcl2-specific inhibitor venetoclax/ABT199 were from AbbVie and Genentech (animal use) and LC Laboratory (for in vitro use). The use of other kinase inhibitors has been described (33 (link),34 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!